◆ 会议时间：2025年7月3-4日
◆ 会议地点：韩国 首尔

◆ 会议简介：

2025年第5届亚洲肿瘤学术大会暨第第51届韩国癌症协会(KCA)年会将于2025年7月3-4日在韩国首尔举行。

韩国癌症协会(KCA)成立于1974年，是致力于推进韩国肿瘤学发展的最权威的科学协会。KCA代表着来自 150余个机构的2,000多名成员，他们是临床肿瘤学家和基础科学家，并不断扩大其在亚洲的学术知名度和影响力。KCA是国际抗癌联盟(UICC)的成员，也是亚洲肿瘤学会(AOS)的理事会成员。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

The 5th International Conference of the Asian Oncology Society (AOS 2025)
in conjunction with the 51st Annual Meeting of the Korean Cancer Association

会期/Date:
July 3-4, 2025

会場/Venue:
COEX, Seoul, Korea

テーマ/Theme:
Connect and Collaborate to Conquer Cancer.

Hosted by： Asian Oncology Society
Organized by: Korean Cancer Association (KCA)

摘要征文投稿：

Deadline for Abstract Submission : by March 31, 2025

点此提交摘要>>>Submit Abstract>>>

Presentation Type

• Outstanding Abstract
 - Selected original articles that is Not presented in international conferences; Presented in English.
 - Selected presentations who demonstrate the highest levels of scientific and clinical impact will be recognized by scientific committee.

• Oral Presentation: Presented in English

• Poster Presentation

1) All abstracts must be written in English and submitted through the congress website.
2) Select your preferred type for your presentation. The Scientific Committee, however, reserves the right to make the final decision on the mode of presentation.
3) Submission of an abstract implies that the presenting author has the consent of all authors and has obtained necessary institutional clearances.
4) Submission of an abstract acknowledges acceptance for the abstract to be published in the official proceedings.
5) The presenting author must register at the time of acceptance of his or her abstract.
6) Previously published abstracts in cancer-related meetings can be also submitted as well as new unpublished abstracts.
7) The Scientific Committee will review all submitted abstracts. The reviewing process is confidential and decisions are final.
8) Presenting authors must register in the congress through the website by May 29, 2025 (KST).

• Word Limit: 250 words
• The abstract body of original articles should be structured chronologically into 4 sections
• 1) Purpose - 2) Methods - 3) Results - 4) Conclusions

• Word Limit: 150 words
• Case Reports are not encouraged and are considered only if justified by their unique significance or depth of studies on the case.
• The abstract should be unstructured and its length should not exceed 150 words.
  

• Abstract Acceptance: Mid-May, 2025
• All submitted abstracts will be reviewed by the Scientific Committee according to standard review procedures.
Notification of acceptance will be sent by e-mail to presenting (submitting) and corresponding authors.
• If your abstract is accepted, presenting authors must register in the meeting through the website by May 29, 2025.

• For any questions related to abstract submission, please contact the AOS 2025 secretariat..
• If the presenting author of an accepted abstract does not register by the pre-registration date, the abstract will be automatically withdrawn from the final program.

Dear Colleagues and Friends,

It is with great delight that we invite you to join us on the momentous occasion of the 5th International Congress of the Asian Oncology Society (AOS 2025), held in conjunction with the 51st Annual Meeting of the Korean Cancer Association, in Seoul, Korea on July 3-4, 2025.

AOS 2025 promises to be an extraordinary gathering under the theme, "Connect and Collaborate to Conquer Cancer." This theme reflects the core of our mission - build meaningful connections, foster multidisciplinary collaborations, and empower each other as we advance cancer research and treatment.

Following the success of AOS 2022 in Seoul, AOS 2025 will once again serve as an unparalleled platform for sharing knowledge, exploring the latest innovations, and collaborating with colleagues from diverse backgrounds to drive impactful change. We are confident that the congress will not only offer valuable insights but also inspire and empower participants to drive meaningful change together.

Be sure to mark your calendar for this must-attend congress and join us at AOS 2025.
We look forward to welcoming you to Seoul, Korea.

Sincerely yours,

Sun Young Rha, MD, PhD
President
AOS 2025 Organizing Committee

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。